Modeling the Risk of Hearing Loss From Radiation Therapy in Childhood Cancer Survivors: A PENTEC Comprehensive Review
International Journal of Radiation Oncology*Biology*Physics · 2024-06 · 119 (2) · 446-456
DOI: 10.1016/j.ijrobp.2023.08.016 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2024-06. Verfasst von Blair Murphy und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Medicine, Oregon Health & Science University, Doernbecher Children's Hospital, Portland, Oregon. Electronic address: murphbl@…. Hauptthemen laut MEDLINE: Hearing Loss, Cochlea, Cancer Survivors. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: American Association of Physicists in Medicine.
Abstract (Originalsprache)
PURPOSE: The Pediatric Normal Tissue Effects in the Clinic (PENTEC) hearing loss (HL) task force reviewed investigations on cochlear radiation dose-response relationships and risk factors for developing HL. Evidence-based dose-response data are quantified to guide treatment planning. METHODS AND MATERIALS: A systematic review of the literature was performed to correlate HL with cochlear dosimetry. HL was considered present if a threshold exceeded 20 dB at any frequency. Radiation dose, ototoxic chemotherapy exposure, hearing profile including frequency spectra, interval to HL, and age at radiation therapy (RT) were analyzed. RESULTS: Literature was systematically reviewed from 1970 to 2021. This resulted in 739 abstracts; 19 met inclusion for meta-analysis, and 4 included data amenable to statistical modeling. These 4 studies included 457 cochleas at risk in patients treated with RT without chemotherapy, and 398 cochlea treated with chemotherapy. The incidence and severity of cochlear HL from RT exposure alone is related to dose and age. Risk of HL was 3 years of age. High-frequency HL was most common, with average onset occurring 3.6 years (range, 0.4-13.2 years) after RT. Exposure to platinum-based chemotherapies added to the rates of HL at a given cochlear dose level, with 300 mg/m2 shifting the dose response by 7 Gy. CONCLUSIONS: In children treated with RT alone, risk of HL was low for cochlear dose
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiation Medicine, Oregon Health & Science University, Doernbecher Children's Hospital, Portland, Oregon. Electronic address: murphbl@ohsu.edu.
- Memorial Sloan Kettering Cancer Center, New York, New York.
- Rehabilitation Services, St. Jude Children's Research Hospital, Memphis, Tennessee.
- Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, The Netherlands; Division of Childhood Cancer Epide…
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Emma Children's Hospital, Amsterdam UMC Location AMC, Amsterdam, The Netherlands.
Förderung
- American Association of Physicists in Medicine
Zitieren
APA
Murphy, B., Jackson, A., Bass, J. K., Tsang, D. S., Ronckers, C. M., Kremer, L., Baliga, S., Olch, A., Zureick, A. H., Jee, K. W., Constine, L. S., & Yock, T. I. (2024). Modeling the Risk of Hearing Loss From Radiation Therapy in Childhood Cancer Survivors: A PENTEC Comprehensive Review. International Journal of Radiation Oncology*Biology*Physics, 119(2), 446-456. https://doi.org/10.1016/j.ijrobp.2023.08.016
Vancouver
Murphy B, Jackson A, Bass JK, Tsang DS, Ronckers CM, Kremer L, et al. Modeling the Risk of Hearing Loss From Radiation Therapy in Childhood Cancer Survivors: A PENTEC Comprehensive Review. International Journal of Radiation Oncology*Biology*Physics. 2024;119(2):446-456. doi:10.1016/j.ijrobp.2023.08.016
BibTeX
@article{Murphy2024,
author = {Murphy, Blair and Jackson, Andrew and Bass, Johnnie K and Tsang, Derek S and Ronckers, Cecile M and Kremer, Leontien and Baliga, Sujith and Olch, Arthur and Zureick, Andrew H and Jee, Kyung-Wook and Constine, Louis S and Yock, Torunn I},
title = {Modeling the Risk of Hearing Loss From Radiation Therapy in Childhood Cancer Survivors: A PENTEC Comprehensive Review},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2024},
volume = {119},
number = {2},
pages = {446--456},
doi = {10.1016/j.ijrobp.2023.08.016}
}
EUVIMED